- Synthesis of asymmetrically disubstituted anthracenes
-
We have developed synthetic pathways toward differently substituted hydroxyanthracenes (anthrols) with the aim to investigate their photochemical reactivity in dehydration reactions. Although the syntheses of anthracenes substituted at positions 9,10 are well known, reports for the synthesis of anthracenes with different substitution patterns are scarce. Herein we review known and report novel synthetic pathways toward anthrols with substituents at 1,2-, 2,3-, and 2,6- positions. We present two synthetic approaches: (i) building of the anthracene tricyclic fused ring system from the appropriate benzene derivatives, and (ii) reduction of the corresponding anthraquinones. Reduction of 2-hydroxyanthracene-1-carbaldehyde to the corresponding alcohol yields rather unexpected 1,1′-methylenedianthracen-2-ol, whose proposed mechanism of formation is supported by experimental observations and calculations.
- ?kalamera, ?ani,Veljkovi?, Jelena,Pti?ek, Lucija,Sambol, Matija,Mlinari?-Majerski, Kata,Basari?, Nikola
-
supporting information
p. 5892 - 5899
(2017/09/09)
-
- One-pot synthesis of tetralin derivatives from 3-benzoylpropionic acids: Indium-catalyzed hydrosilylation of ketones and carboxylic acids and intramolecular cyclization
-
This reducing system was composed of a small amount (1 mol%) of In(OAc)3, Me2PhSiH, and I2 that effectively catalyzed the hydrosilylation of two different carbonyl groups, a ketone and a carboxylic acid found in 3-benzoylpropionic acids, followed by a subsequent intramolecular cyclization that led to the one-pot preparation of tetralin derivatives.
- Sakai, Norio,Kobayashi, Taichi,Ogiwara, Yohei
-
supporting information
p. 1503 - 1505
(2015/11/24)
-
- Synthesis of uniformly 13C-labeled polycyclic aromatic hydrocarbons
-
Convergent synthetic pathways were devised for efficient synthesis of a series of uniformly 13C labeled polycyclic aromatic hydrocarbons de novo from U-13C-benzene and other simple commercially-available 13C-starting compounds. All target products were obtained in excellent yields, including the alternant PAH U-13C-naphthalene, U-13C-phenanthrene, U-13C-anthracene, U- 13C-benz[a]anthracene, U-13C-pyrene and the nonalternant PAH U-13C-fluoranthene.
- Zhang, Zhenfa,Sangaiah, Ramiah,Gold, Avram,Ball, Louise M.
-
p. 5431 - 5435
(2011/09/14)
-
- AMIDE COMPOUND
-
The present invention relate to a compound represented by the formula (I) or (II) wherein ring A is an optionally substituted ring (the ring should not be pyrrolidine, piperidine and piperazine), ring B is an optionally substituted aromatic ring, ring D is an optionally substituted ring, R1 and R2 are each independently a hydrogen atom or a substituent, R3 is a hydrogen atom or a C1-6 alkyl group, or R3 is bonded to ring A to form a non-aromatic ring, ring Aa is an optionally substituted aromatic hydrocarbon, Y is CH or N, Ra1 is an optionally substituted hydrocarbon group, and Ra2 and Ra3 are each independently a hydrogen atom or a substituent, or a salt thereof. The present invention provides a compound having a DGAT inhibitory activity, which is useful for the treatment or amelioration of diseases or pathologies caused by high expression or high activation of DGAT.
- -
-
-
- AMIDE COMPOUND
-
Disclosed is a compound represented by the formula (I) or (II) below, or a salt thereof. [In the formulae, ring A represents an optionally substituted ring (which is not a pyrrolidine, piperidine or piperazine); ring B represents an optionally substituted aromatic ring; ring D represents an optionally substituted ring; R1 and R2 independently represent a hydrogen atom or a substituent; R3 represents a hydrogen atom or a C1-6 alkyl group, or alternatively it combines with the ring A to form a non-aromatic ring; ring Aa represents an optionally substituted aromatic hydrocarbon; Y represents CH or N; Ra1 represents an optionally substituted hydrocarbon group; and Ra2 and Ra3 independently represent a hydrogen atom or a substituent.] The compound has a DGAT inhibitory effect and is useful for treatment or improvement of diseases or conditions caused by high expression or high activation of DGAT.
- -
-
Page/Page column 84-85
(2008/06/13)
-
- The thermodynamic properties of 4-methylphenanthrene
-
Measurements leading to the calculation of the ideal-gas thermodynamic properties for 4-methylphenanthrene are reported.Thermochemical and thermophysical properties were determined by adiabatic heat-capacity calorimetry, combustion calorimetry, comparative ebulliometry, and inclined-piston manometry.Results were used to calculate entropies, enthalpies, and Gibbs energies of formation for the ideal-gas state at selected temperatures to 500 K.Group-contribution methods involving comparisons for a series of methyl-substituted aromatic molecules were used to demonstrate the consistency of ideal-gas entropies and the enthalpy of formation determined for 4-methylphenanthrene with literature values for related compounds.The results are shown to be in accord with a barrier to methyl rotation from the literature determined using n.m.r. spectroscopy.
- Chirico, R. D.,Hossenlopp, I. A.,Nguyen, A.,Steele, W. V.,Gammon, B. E.
-
p. 179 - 202
(2007/10/02)
-